Patients taking modem blood pressure and cholesterol drugs significantly reduce their risk of suffering a heart attack within 90 days of starting treatment, researchers said last month. New analysis from a 19,000-patient study sponsored by Pfizer Inc. showed its cholesterol drug Lipitor used alongside its antihypertensive Norvasc reduced the risk of fatal and non-fatal cardiac events by 53 percent, with the benefits evident after only three months.
